Caixin
Feb 03, 2022 08:29 PM
BUSINESS

Chinese Covid-Vaccine Makers Predict Strong Profits for 2021

China has made vaccinating its entire population a top priority. Photo: Yang Bo/China News Service, VCG
China has made vaccinating its entire population a top priority. Photo: Yang Bo/China News Service, VCG

Major Chinese vaccine makers are expecting to report a major surge in profits last year on the back of the nationwide Covid-19 inoculation program that has seen more than 3 billion doses administered, the biggest such rollout in the world.

Tianjin-based CanSino Biologics Inc. (688185.SH), which makes a single-dose vaccine, estimated it would book 1.85 billion yuan ($290.6 million) to 2 billion yuan in net profits attributable to shareholders in 2021, a reversal from a net loss of 397 million yuan for the previous year, according to a Saturday company filing.

You've accessed an article available only to subscribers
VIEW OPTIONS
Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
Caixin China Biz Roundup: New ‘Langya’ Virus Detected in China
00:00
00:00/00:00